Aspects of quality of life in gastrointestinal disease: Some methodological issues

Scandinavian Journal of Gastroenterology

Volumn 30, Issue S208, 1995, Pages 129-132

  Wiklund, I ^a  

^a ASTRAZENECA R AND D   (Sweden)

Author keywords

Gastrointestinal symptoms; Methods; Quality of Life

Indexed keywords

ARTICLE; FEMALE; GASTROINTESTINAL DISEASE; HUMAN; MALE; PSYCHOLOGICAL ASPECT; QUALITY OF LIFE; QUESTIONNAIRE; PRIORITY JOURNAL; REVIEW;

FEMALE; GASTROINTESTINAL DISEASES; HUMAN; MALE; QUALITY OF LIFE; QUESTIONNAIRES;

EID: 0028938308     PISSN: 00365521     EISSN: None     Source Type: Journal    
DOI: 10.3109/00365529509107774     Document Type: Article

References (35)

1. Measuring Quality of Life in clinical trials: a taxonomy and review
2. Health and social factors related to life satisfaction
3. State of science 1986;Quality of Life and functional status as target variables for research
4. Quality of Life measures in health care. I: Applications and issues in assessment
5. Laparoscopic Rosetti fundoplication
6. Health-related Quality of Life assessments and the pharmaceutical industry
7. Cost and quality effects of alternative treatments for persistent gastroesophageal reflux disease
8. The cost-effectiveness of omeprazole and ranitidine in intermittent and maintenance treatment of reflux esophagitis-the case of Sweden
9. A one year model for the cost-effectiveness of treating reflux esophagitis
10. Comparing the cost-effectiveness of drug regimens in the treatment of duodenal ulcers
11. Do psychological studies upset patients?
12. A methodological framework for assessing health indices
13. Quality of Life assessment: Can we keep it simple?
14. Quality of Life assessments in clinical trials: methodological issues
15. Assessing the Quality of Life in patients in cancer clinical trials: common sense problems and common sense solutions
16. Factors of importance when evaluating Quality of Life in clinical trials
17. Can gastritis symptoms be evaluated in clinical trials? An overview of treatment of gastritis, non-ulcer dyspepsia and Campylobacter -associated gastritis
18. A new measure of health status for clinical trials in inflammatory bowel disease
19. The rating form of IBD patients concerns: a new measure of health status
20. A patient questionnaire to identify bowel diasease
21. Quality of Life in patients with upper gastrointestinal symptoms. An improved evaluation of treatment regimens?
22. Well-being and gastrointestinal symptoms among patients referred to endoscopy due to suspected duodenal ulcer
23. Effect of cisapride therapy for severe dyspepsia on gastrointestinal symptoms and Quality of Life
24. Evaluation of Quality of Life in clinical trials: selecting Quality of Life measures
25. Quality of Life studies from the perspective of an FDA reviewing statistician
26. Symptom relief and the placebo effect in the trial of an anti-peptic drug
27. Treatment with cimetidine, antacid, or placebo in patients with dyspepsia of unknown origin
28. Once-daily bedtime dosing regimen of cimetidine in the treatment of gastric ulcer
29. Relief of epigastric pain in non-ulcer dyspepsia: controlled trial of the promotility drug cisapride
30. Nizatidine versus placebo in gastroesophageal reflux disease; a 12-week, multicenter, randomized, double-blind study
31. Quality of Life measures in health care. II: Design, analysis, and interpretation
32. Socio-economic factors, health care consumption and rating of abdominal symptom severity. A report from the abdominal symptom study
33. Epidemiology of colonic symptoms and the irritable bowel syndrome
34. Dyspepsia and dyspepsia subgroups: a population-based study